These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7904509

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
    Saxena R, Shaw GL, Relling MV, Frame JN, Moir DT, Evans WE, Caporaso N, Weiffenbach B.
    Hum Mol Genet; 1994 Jun; 3(6):923-6. PubMed ID: 7951238
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia.
    Dawson E, Powell JF, Nöthen MM, Crocq MA, Lanczik M, Körner J, Rietschel M, van Os J, Wright P, Gill M.
    Psychiatr Genet; 1994 Jun; 4(4):215-8. PubMed ID: 7712118
    [Abstract] [Full Text] [Related]

  • 27. An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis.
    Broly F, Marez D, Sabbagh N, Legrand M, Millecamps S, Lo Guidice JM, Boone P, Meyer UA.
    Pharmacogenetics; 1995 Dec; 5(6):373-84. PubMed ID: 8747409
    [Abstract] [Full Text] [Related]

  • 28. The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population.
    Armstrong M, Fairbrother K, Idle JR, Daly AK.
    Pharmacogenetics; 1994 Apr; 4(2):73-81. PubMed ID: 8081414
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: a case of genetic divergence with tentative phylogenetic time frame for the pathway.
    Arias TD, Inaba T, Cooke RG, Jorge LF.
    Clin Pharmacol Ther; 1988 Sep; 44(3):343-52. PubMed ID: 3416554
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Debrisoquin and S-mephenytoin hydroxylation phenotypes and CYP2D6 genotypes in an Estonian population.
    Marandi T, Dahl ML, Kiivet RA, Rägo L, Sjöqvist F.
    Pharmacol Toxicol; 1996 May; 78(5):303-7. PubMed ID: 8737964
    [Abstract] [Full Text] [Related]

  • 34. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU, Asante-Poku S, Ofori-Adjei D, Mikus G, Eichelbaum M.
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [Abstract] [Full Text] [Related]

  • 35. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.
    Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thal LJ, Hansen LA, Katzman R.
    Ann Neurol; 1995 Jan; 37(1):110-2. PubMed ID: 7818242
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
    Evans WE, Relling MV.
    Mol Pharmacol; 1990 May; 37(5):639-42. PubMed ID: 1971090
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.